Article info

Download PDFPDF
Analysis of FDA’s IQOS marketing authorisation and its policy impacts

Authors

  1. Correspondence to Professor Stanton Glantz, Center for Tobacco Control Research and Education, University of California, San Francisco CA 94143, California, USA; Stanton.Glantz{at}ucsf.edu
View Full Text

Citation

Lempert LK, Glantz S
Analysis of FDA’s IQOS marketing authorisation and its policy impacts

Publication history

  • Received December 21, 2019
  • Revised April 29, 2020
  • Accepted May 5, 2020
  • First published June 29, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.